Home › Funds › Cormorant Asset Management, LP › ELVN

Cormorant Asset Management, LP position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

Cormorant Asset Management, LP reported holding 150,000 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$7.6M, representing 0.39% of its reported portfolio and ranking #36 among its reported holdings. Cormorant Asset Management, LP has disclosed ELVN holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)150.00K sh
Reported value held$7.61M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ELVN position evolved

Cormorant Asset Management, LP first disclosed a stake in ELVN in Q3 2023 at 1,216,712 shares (US$16.6M). Across 6 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 150,000 shares valued at US$7.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.22M $16.62M New
Q4 2024 250.00K $5.62M New
Q1 2025 250.00K $4.92M Hold
Q2 2025 200.00K $4.01M Reduce
Q3 2025 200.00K $4.09M Hold
Q2 2026 150.00K $7.61M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 68 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$326.4M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has Cormorant Asset Management, LP held ELVN?

Cormorant Asset Management, LP has disclosed ELVN holdings in 6 of the last 12 reported quarters, going back to Q3 2023.

What is Cormorant Asset Management, LP's current position in ELVN?

As of Q2 2026, Cormorant Asset Management, LP holds 150.00K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $7.61M, representing 0.39% of its reported portfolio and ranking #36.

Has Cormorant Asset Management, LP been buying or selling ELVN?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP newly opened its position in ELVN.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.